Dura, Drug Royalty, Eli Lilly deal

DURA acquired exclusive U.S. marketing rights for two Lilly antibiotics, Keftab (cephalexin hydrochloride) and Ceclor CD (cefaclor extended release tablets) for $100 million (see BioCentury Extra Aug. 23). ...